ReviewLeukemia2002
Nuclear transcription factor-kappaB as a target for cancer drug development.
A Garg et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
150 papers cite itlatest 60 shown
this papercites it
ReviewLeukemia2002
A Garg et al.PubMed ↗Publisher ↗
No numbers read from the abstract.